Andrew Brackmann

Andrew Cooper

Mason Carrico

Puneet Souda

Daniel Brennan

David Westenberg

Michael Ryskin

Tejas Savant

Vidyun Bais

John Wilkin

Laura Gris Trillo

Mark Massaro

Matthew Sykes

Michael Matson

Mike Matson

Thomas VonDerVellen

Yuko Oku

Dan Brennan

Jack Meehan

Joseph Conway

Matthew Hewitt

Mike Ryskin

Prashant Kota

Tycho Peterson

- The District Court for the Middle District of North Carolina **ruled in favor of NeoGenomics** in a patent infringement lawsuit against Natera.  **[1077183_05c8d03e8c4c410cac29e43062fafacb_0]** 
- The Court granted NeoGenomics' motion for summary judgment, declaring **all of Natera's asserted patent claims invalid** for claiming ineligible subject matter.  **[1077183_05c8d03e8c4c410cac29e43062fafacb_0]** 
- This decision means NeoGenomics **remains free to broadly commercialize its RaDaR ST molecular residual disease (MRD) assay** in the United States.  **[1077183_05c8d03e8c4c410cac29e43062fafacb_0]** 
- NeoGenomics has already **launched the RaDaR ST assay to biopharma customers** and has submitted it for clinical reimbursement coverage to the Centers for Medicare & Medicaid Services’ (CMS) Molecular Diagnostic Services Program (MolDX).  **[1077183_05c8d03e8c4c410cac29e43062fafacb_0]**

NeoGenomics Wins Patent Infringement Lawsuit Against Natera

NEOGENOMICS (NEO)